McKillop I, Haylor J, el Nahas A M
Sheffield Kidney Institute, Northern General Hospital, UK.
Exp Nephrol. 1995 Jan-Feb;3(1):49-57.
IGF-I is known to increase renal function when administered in vivo. To establish whether IGF-I has a direct effect on renal function, the present experiments were performed to measure the effects of IGF-I in the isolated perfused rat kidney (IPRK). We have examined the influence of l-nitroarginine methyl ester (l-NAME), a non-selective inhibitor of nitric oxide synthase (NOS) and aminoguanidine (AG), a selective inhibitor of the inducible isoform of NOS on the direct effects of recombinant human IGF-I (rhIGF-I) on renal function in the IPRK. rhIGF-I (100 nM) increased both glomerular filtration rate (GFR) (+109 +/- 17%, n = 6, p < 0.01) and renal perfusate flow (RPF) (+100 +/- 15%, n = 6, p < 0.01), effects which were completely blocked by l-NAME (10 microM). In the presence of the enantiomer d-NAME (10 microM, n = 6) which is not an inhibitor of NOS, rhIGF-I (100 nM) still produced a significant increase in both GFR (+175 +/- 15%, n = 6, p < 0.01) and RPF (+94 +/- 7%, n = 6, p < 0.01). AG blunted the renal haemodynamic response to rhIGF-I (GFR +49 +/- 10, RPF + 31 +/- 7, n = 6, p < 0.05), but unlike l-NAME, did not abolish it. The haemodynamic responses of the IPRK to rhIGF-I in the presence of AG were significantly greater than those of rhIGF-I in the presence of l-NAME (p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
已知胰岛素样生长因子-I(IGF-I)在体内给药时可增强肾功能。为确定IGF-I是否对肾功能有直接作用,进行了本实验以测量IGF-I对离体灌注大鼠肾脏(IPRK)的影响。我们研究了一氧化氮合酶(NOS)的非选择性抑制剂L-硝基精氨酸甲酯(L-NAME)和诱导型NOS同工型的选择性抑制剂氨基胍(AG)对重组人IGF-I(rhIGF-I)对IPRK肾功能直接作用的影响。rhIGF-I(100 nM)可使肾小球滤过率(GFR)升高(+109±17%,n = 6,p < 0.01)和肾灌注液流量(RPF)升高(+100±15%,n = 6,p < 0.01),这些作用被L-NAME(10 μM)完全阻断。在不是NOS抑制剂的对映体D-NAME(10 μM,n = 6)存在的情况下,rhIGF-I(100 nM)仍使GFR(+175±15%,n = 6,p < 0.01)和RPF(+94±7%,n = 6,p < 0.01)显著升高。AG减弱了对rhIGF-I的肾血流动力学反应(GFR +49±10,RPF + 31±7,n = 6,p < 0.05),但与L-NAME不同,并未消除该反应。在AG存在的情况下,IPRK对rhIGF-I的血流动力学反应显著大于在L-NAME存在时rhIGF-I的反应(p < 0.05)。(摘要截短于250字)